Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


To SEC-MALS & Beyond - The Road to Biotherapeutic Development Illuminated by Light Scattering

01 Oct 2013 - 01 Oct 2013 - Online Webinar



Bookmark and Share


We present HPLC/SEC-MALS, the technique for quantifying absolute molecular weight, size, polydispersity, aggregation and degree of conjugation. Developers of biopharmaceuticals rely on Wyatt Technology's SEC-MALS products to navigate the path to drug product with confidence.  We review how the Wyatt light scattering instruments constitute a unique set of orthogonal and complementary methods alongside SEC-MALS: SEC-DLS for size & conformation; FFF-MALS for separation & characterization; CG-MALS for intermolecular interactions, and microwell plate-based DLS for high-throughput screening.

Who should attend:
• Researchers assessing biomolecular quality, including size and concentration of aggregates, degree of polymer conjugation, and column interactions
• Protein chemists optimizing production, modification, and formulation of biotherapeutic lead molecules
• Laboratory Managers/Directors/Supervisors performing biophysical characterization

Questions to be answered:
• How do MALS and DLS increase the chromatography data value for advanced analysis of IgG, ADCs, PEGylated proteins, and new format biotherapeutics?
• How can batch light scattering contribute to assessing stability and developing robust formulations?



Further information
Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!